Niebvll
Stop the rHGH Cope
- Joined
- Sep 4, 2025
- Posts
- 11,582
- Reputation
- 16,542
@claygo funny high iq larp you posted
Lets see what kind of info he's gonna "spoonfeed" us
Perhaps a humble genius?
Regarding the other claim that type x collagen somehow noticeably influences the chondrocyte differentiation, theres a reason why literally 0 evidence is given. Type x collagen is primarily a marker of hypertrophy and is exclusively secreted in chondrocytes that have entered senescence. The deletion of Col10a1 proved that type x collagen is completely dispensable for differentiation but also that absence of the former faciliates the latter. Showing that the absence of type x collagen increases chondrocyte differentiation into hypertrophy, it's presence leads to a longer stay in a proliferative phase. Both FGFR1 and FGFR2 primarily cause collagen x downregulation by affecting the responsible transcription factors, this would again faciliate differentiation and thus be counterproductive. FGFR3 Inhibition however consistently upregulates it which results in greater proliferation before hypertrophy. Whether this has any significant effects is very questionable and would presume that the secretion has noticeable effects extracellularly, I would argue most of the matters have already been decided by pathways upstream. Observations like this could also be reverse causality.
You also didnt really give any specification or go into detail on how this would work? I would kind of expect that when putting forth such a ground breaking theory.
And how does "erda doesnt work as you think it does" conclude in "erda has more roi than all other compounds"



Big ego for just joiningHello, uh, I’ll be honest: I just joined this forum. I know a lot about pharma, so I figured I’d spoon feed y’all from now on, I guess...
Lets see what kind of info he's gonna "spoonfeed" us
Okay backing down a little bitDisclaimer: this shit is probably water for high iq people(i doubt there are any on this forum though lmao), but for the average pharma dude, it isn’t.
Perhaps a humble genius?
Bold claim when literally all of literature supports that it isSo, you may have seen some erdafitinib edits on TikTok showing studies where erdafitinib delays growth plate closure and also widens them.
So the pharma retards think this is from inhibition of fgfr3, but it’s not.
I would guess because the potency with tyra is worse lol. Others like infig also have metabolism issues that Erda doesnt have.You will only see this effect on erda and not other "better" fgfr inhibitors such as tyra. Why?
saying this as if fgfr3 inhibition isnt potentWell, this growth plate effect of erda comes from potent inhibition of fgfr1-2
FGFR1 signalling is indeed thought of to be growth-inhibiting, however loss of function shows 0 increase in adult height (so it's inhibition is fairly useless) and only a transient increase in hypertrophic zone height, not even anything permanent lol. FGFR2 signalling however is seen to be growth-promoting and it's msc inactivation actually led to dwarfism [PMC4133284, PMC8965158], its shown in people with both fgfr2 gain or loss of function mutations that they end up with significantly decreased adult heights, while we see a clear differentiation between height results with fgfr3 overexpression and deletion. That does imply that it is fgfr3 inhibition which leads to the actual height increases while fgfr2 must be balanced out.which alters the FGFR1/2–MAPK/ERK signaling axis in hypertrophic chondrocytes, increasing the COL10A1 (type X collagen)-positive hypertrophic zone and disrupting the normal transition from proliferating → hypertrophic chondrocytes → endochondral ossification, thereby expanding/widening the growth plate
(holy spoon feed)
Regarding the other claim that type x collagen somehow noticeably influences the chondrocyte differentiation, theres a reason why literally 0 evidence is given. Type x collagen is primarily a marker of hypertrophy and is exclusively secreted in chondrocytes that have entered senescence. The deletion of Col10a1 proved that type x collagen is completely dispensable for differentiation but also that absence of the former faciliates the latter. Showing that the absence of type x collagen increases chondrocyte differentiation into hypertrophy, it's presence leads to a longer stay in a proliferative phase. Both FGFR1 and FGFR2 primarily cause collagen x downregulation by affecting the responsible transcription factors, this would again faciliate differentiation and thus be counterproductive. FGFR3 Inhibition however consistently upregulates it which results in greater proliferation before hypertrophy. Whether this has any significant effects is very questionable and would presume that the secretion has noticeable effects extracellularly, I would argue most of the matters have already been decided by pathways upstream. Observations like this could also be reverse causality.
You also didnt really give any specification or go into detail on how this would work? I would kind of expect that when putting forth such a ground breaking theory.
what the fuck is this reasoning LOLConclusion
Erda is probably the highest ROI height compound in com because it’s cheap as fuck, has lots of studies, and yeah lmao
And how does "erda doesnt work as you think it does" conclude in "erda has more roi than all other compounds"
Please dontNote: If I get a lot of reps on this post, I’ll start posting high effort shit with good formatting and more information/studies included, etc.
Because you made it all up?(Trust me, I know stuff you guys have never heard of.)
Last edited:
